Methyl jasmonate induced apoptosis in human prostate carcinoma cells via 5-lipoxygenase dependent pathway

Journal of Experimental Therapeutics and Oncology

Volumn 6, Issue 4, 2007, Pages 267-277

  Ezekwudo, Daniel E ^a,c   Wang, Robert C ^b   Elegbede, J Abiodun ^a  

^a UNIVERSITY OF NEVADA   (United States)

^b UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

^c MERCER UNIVERSITY   (United States)

Author keywords

Apoptosis; Cell proliferation; DU 145; Jasmonates; Lipoxygenase; PC 3; Prostate cancer

Indexed keywords

5 HYDROXYICOSATETRAENOIC ACID; ARACHIDONATE 5 LIPOXYGENASE; JASMONIC ACID METHYL ESTER;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG STRUCTURE; ENZYME ACTIVITY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; IMAGE ANALYSIS; KINETICS; PRIORITY JOURNAL; PROSTATE CARCINOMA;

ACETIC ACIDS; ANTICARCINOGENIC AGENTS; APOPTOSIS; ARACHIDONATE 5-LIPOXYGENASE; CELL CYCLE; CELL LINE, TUMOR; CYCLOPENTANES; HUMANS; MALE; OXYLIPINS; PROSTATIC NEOPLASMS;

EID: 36148943488     PISSN: 13594117     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Parkin D, Pisani P, Ferlay J: Global cancer statistics. CA Cancer J Clin 49: 33-64, 1999.
2. American Cancer Society: Cancer Facts and Figures, American Cancer Society, Inc. 2006, Atlanta, GA (2006).
3. Landis S, Murray T, Bolden S, Wingo P: Cancer statistics. CA Cancer J Clin 49: 8-31, 1999.
4. Boyle P, Severi G, Giles G: The epidemiology of prostate cancer. Urol Clin North Am 30(2): 209-17, 2003.
5. Zhou J, Yu L, Zhong Y, Blackburn G: Soy phytochemicals and tea bioactive components synergistically inhibit androgen-sensitive human prostate tumors in mice. J Nutr 133: 516-521, 2003.
6. Wattenberg L: Inhibition of neoplasia by minor dietary constituents. Cancer Res (Supplement) 43: 2448-2453, 1983.
7. Elegbede J, Elson C, Tanner M, Qureshi A, Gould M: Inhibition of DMBA-induced mammary cancer by the monoterpene d-limonene. Carcinogenesis 5: 661-664, 1984.
8. Elegbede J, Elson C, Tanner M, Qureshi A, Gould M: Regression of rat mammary tumors following dietary d-limonene. J. Natl. Cancer Inst 76: 323-325, 1986.
9. Haag J, Gould M: Mammary carcinoma regression induced by perillyl alcohol, a hydroxylated analog of limonene. Cancer Chemotherapy and Pharmacology 34: 477-483, 1994.
10. Crowell P, Siar A, Burke Y: Antitumorigenic effects of limonene and perillyl alcohol against pancreatic and breast cancer. Adv Exp Med Biol 401: 131-136, 1996.
11. Clark S, Perman S, Sahin M, Jenkins G, Elegbede J: Antileukemia activity of perillyl alcohol (POH): uncoupling apoptosis from G0/G1 arrest suggests that the primary effect of POH on Bcr/Abl-transformed cells is to induce growth arrest. Leukemia 16(2): 213-222, 2002.
12. Vigushin D, Poon G, Boddy A, English J, Halbert G, Pagonis C, Jarman M, Coombes R: Phase I and pharmacokinetic study of D-limonene in patients with advanced cancer. Cancer Chemother Pharmacol 42: 111-117, 1998.
13. Ripple G, Gould M, Arzoomanian R, Alberti D, Feierabend C, Simon K, Binger K, Tutsch K, Pomplun M, Wahamaki A, Marnocha R, Wilding G, Bailey H: Phase I clinical and pharmacokinetic study of perillyl alcohol administered four times a day. Clin Cancer Res 6: 390-396, 2000.
14. Murren J, Pizzorno G, DiStasio S, McKeen A, Peccerillo K, Gollerkari A, McMurray W, Rutherford T, Li X, Ho P, Sartorelli A: Phase 1 study of perillyl alcohol in patients with refractory malignancies. Cancer Biol Therapy 1(2): 130-135, 2002.
15. Sembdner G, Parthier B: The biochemistry and the physiological and molecular actions of jasmonates. Annu Rev Physiol Plant Mol Biol 44: 569-589, 1993.
16. Farmer E, Ryan C: Interplant communication: air-borne methyl jasmonate induces synthesis of proteinase inhibitors in plant leaves. Proc Natl Acad Sci USA 87: 7713-7716, 1990.
17. Dangl J, Dietrich R, Richberg M: Death don't have no mercy: cell death programs in plant-microbe interactions. Plant Cell 8: 1793-1807, 1996.
18. Mitler R, Lam E: Sacrifice in the face of foes: pathogen-induced programmed cell death in higher plants. Trends Microbiol 4: 10-15, 1996.
19. Weber H, Vick B, Farmer E: Dinor-oxo-phytodienoic acid: A new hexadecanoid signal in the jasmonate family. Proc. Natl. Acad. Sci. USA 94: 10473-10478, 1997.
20. Liechti R, Farmer E: The jasmonate pathway. Science 296: 1649-1650, 2002.
21. Weber H: Fatty acid-derived signals in plants. Trends Plant Sci 7: 217-224, 2002.
22. Ghosh J, Myers C: Arachidonic acid stimulates prostate cancer cell growth: Critical role for 5-lipoxygenase. Biochem Biophys Res Commun 235: 418-423, 1997.
23. O'Flaherty J, Rogers L, Chadwell B, Owen J, Rao A, Cramer S, Daniel L: 5(S)-Hydroxy-6, 8, 11, 14-E, Z, Z, Z-eicosatetraenoate stimulates PC3 cell signaling and growth by a receptor-dependent mechanism. Cancer Res 62: 6817-6819, 2002.
24. Gupta S, Strivastva M, Ahmad N, Sakamoto K, Bostwick DG, Muktar H: Lipoxygenase-5 is overexpressed in prostate adenocarcinoma. Cancer 91: 737-743, 2001.
25. Ghosh J, Myers C: Inhibition of arachidonate 5-lipoxygenase triggers massive apoptosis in human prostate cancer cells. Proc. Natl. Acad. Sci. USA 95: 13182-13187, 1998.
26. Miller T, Ghosh J, Myers C, Macdonald T: 5-HETE Congeners as modulators of cell proliferation. Bioorg. Med. Chem. Lett 10:913-1916, 2000.
27. Ghosh J: Inhibition of arachidonate 5-lipoxygenase triggers prostate cancer cell death through rapid activation of c-Jun N-terminal kinase. Biochem. Biophys. Res. Comun 307: 342-349, 2003.
28. Fingrut O, Flescher E: Plant stress hormones suppress the proliferation and induce apoptosis in human cancer cells. Leukemia 16: 608-616, 2002.
29. MosmannT: Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63, 1983.
30. Hayes R, Ziegler R, Gridley G, Swanson C, Greenberg R, Schoenberg J, Silverman D,
31. Brown L, Pottern L, Liff J, Schwartz A, Fraumeni J, Hoover R: Dietary factors and risks for prostate cancer among blacks and whites in the United States. Cancer Epidemiol Biomarkers Prevention 8: 25-34, 1997.
32. Gann P, Hennekens C, Sacks F, Grodstein F, Giovannucci E, Stampfer M: Prospective study of plasma fatty acids and risk of prostate cancer. J Natl Cancer Inst 86: 281-286, 1994.